SCHEDULE: A.L. Sarroff Fund Increases Stake in PetVivo Holdings to Nearly 30%

Sentiment:

Beneficial Ownership Disclosure


A.L. Sarroff Fund, LLC has disclosed an increased beneficial ownership of 29.7% in PetVivo Holdings, Inc., holding 6,821,091 common shares as a passive investor.

Summary

  • A.L. Sarroff Fund, LLC, a New York Limited Liability Company, has reported a beneficial ownership of 6,821,091 common shares in PetVivo Holdings, Inc.
  • This stake represents 29.7% of PetVivo Holdings, Inc.'s outstanding common shares, based on 21,251,784 shares outstanding as of December 31, 2024, according to the issuer's latest Form 10-Q.
  • The filing is an Amendment No. 9 to Schedule 13G, indicating a change in beneficial ownership.
  • A.L. Sarroff Fund, LLC also owns 2,213,696 warrants of PetVivo Holdings, Inc., which are not included in the beneficial ownership calculation for this Schedule 13G as they are not currently exercisable.
  • The warrants are exercisable on a schedule: 1,166,000 warrants as of August 4, 2026; 111,000 warrants as of December 6, 2026; 861,696 warrants as of April 29, 2027; 2,500,000 warrants as of July 9, 2027; and 75,000 warrants on June 11, 2028.
  • The reporting person certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer, and that they are not a beneficial owner of 20% or more of the class, despite reporting 29.7%.

Sentiment

Score: 7

Explanation: The disclosure of a significant and increased stake by a major investor (29.7%) can be viewed positively as it signals strong confidence in the company. However, internal inconsistencies regarding the 20% ownership threshold and warrant counts introduce minor concerns.

Positives

  • A.L. Sarroff Fund, LLC has significantly increased its stake in PetVivo Holdings, Inc. to 29.7%, indicating strong conviction in the company's long-term prospects from a major investor.
  • The investor's passive stance, as stated in the filing, suggests a belief in the current management and strategic direction without seeking to influence control.

Negatives

  • The filing contains an internal inconsistency where the reporting person states they are not a beneficial owner of 20% or more of the class, despite reporting a 29.7% ownership. This could lead to questions regarding the accuracy or interpretation of the filing.
  • There is a discrepancy in the stated total number of warrants (2,213,696) versus the sum of the individually listed warrant tranches (4,713,696), which may cause confusion.

Risks

  • The discrepancy between the reported 29.7% beneficial ownership and the certification that the reporting person is not a beneficial owner of 20% or more could raise regulatory scrutiny or questions regarding compliance with SEC Rule 13d-1(c).
  • The significant concentration of ownership (29.7%) by a single entity, even if passive, could influence market perception or liquidity.
  • The large number of unexercised warrants held by A.L. Sarroff Fund, LLC, totaling 2,213,696 (or 4,713,696 based on detailed breakdown), represents potential future dilution if exercised.

Future Outlook

The document does not provide forward-looking statements or guidance from PetVivo Holdings, Inc. It solely details the beneficial ownership position of A.L. Sarroff Fund, LLC.

Management Comments

  • Alan L. Sarroff, Chief Executive Officer and Managing Member of A.L. Sarroff Fund, LLC, certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a standard disclosure of a significant ownership stake by an investment fund in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact that a substantial investor sees value in PetVivo Holdings, Inc.

Comparison to Industry Standards

  • NA

Stakeholder Impact

  • Shareholders: The increased significant stake by A.L. Sarroff Fund, LLC could be perceived as a vote of confidence, potentially influencing investor sentiment. The large number of unexercised warrants represents potential future dilution.
  • Management: The passive nature of the investment, as stated by the fund, suggests no immediate intent to challenge or influence current management, which could provide stability.

Next Steps

  • The document does not outline specific future actions, events, or milestones for PetVivo Holdings, Inc. or A.L. Sarroff Fund, LLC beyond the warrant exercise dates.

Key Dates

DateDescription
2024-09-30Common shares owned and/or controlled by A.L. Sarroff Fund, LLC totaled 29.7% of outstanding common shares.
2024-12-31Date of issuer's latest Form 10-Q, stating 21,251,784 outstanding common shares.
2025-06-11Date of event which requires filing of this statement.
2025-07-10Date of filing of this Schedule 13G.
2026-08-04Exercise date for 1,166,000 warrants.
2026-12-06Exercise date for 111,000 warrants.
2027-04-29Exercise date for 861,696 warrants.
2027-07-09Exercise date for 2,500,000 warrants.
2028-06-11Exercise date for 75,000 warrants.

Recommendation

hold

Keywords

PetVivo Holdings Inc, A.L. Sarroff Fund LLC, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Passive Investment, Warrants, Equity Stake, Shareholder

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.